MRVFF   $0.9849  1.54% Market Closed

Nuvo Pharmaceuticals Inc
Total Cash 31.26M
totalCashPerShare 2.745
EBITDA 19.25M
Total Debt 98.92M
quickRatio 1.681
currentRatio 2.108
Total Revenue 72.42M
debtToEquity 1165.846
Revenue/Share 6.359
ROA 0.05847
ROE 11.80467
grossProfits 44.46M
freeCashflow 10.33M
operatingCashflow 15.54M
earningsGrowth
revenueGrowth 0.067
grossMargins 0.62221
ebitdaMargins 0.26586
operatingMargins 0.16943
profitMargins 0.20947
enterpriseValue 78.82M
forwardPE
floatShares 8.93M
sharesOutstanding 11.39M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.06%
heldPercentInstitutions 0.18%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.745
Price To Book help_outline 1.31
earningsQuarterlyGrowth
netIncomeToCommon 15.17M
trailingEps -0.05%
forwardEps
enterpriseToEbitda 4.09
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 2
lastUpdated May 16, 2023, 2:33 p.m.